Search

Search Constraints

You searched for: Author/Creator Morrone, D

Search Results

2. Annualized clinical event rates during two-year follow-up are low in 27, 617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program. (24th May 2021)

3. Comparison of the efficacy and safety between different oral P2Y12 receptor inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis. (3rd October 2022)

4. Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program. (14th October 2021)

5. Functional correlates of left atrial volume dilatation during vasodilator stress echocardiography. (25th November 2020)

6. Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy. (14th October 2021)

8. Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF. (24th May 2021)

9. P329 Outcome prediction with force-based left ventricular contractile reserve during stress echocardiography. (17th January 2020)